Q2 2016 13F Holders as of 30 Jun 2016
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
4,549,925
-
Share change
-
+1,027,469
-
Total reported value
-
$27,806,219
-
Put/Call ratio
-
16%
-
Price per share
-
$6.13
-
Number of holders
-
43
-
Value change
-
+$6,296,678
-
Number of buys
-
31
-
Number of sells
-
6
Institutional Holders of ARGOS THERAPEUTICS INC - COM (ARGS) as of Q2 2016
As of 30 Jun 2016,
ARGOS THERAPEUTICS INC - COM (ARGS) was held by
43 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
4,549,925 shares.
The largest 10 holders included
WASATCH ADVISORS INC, VANGUARD GROUP INC, BlackRock Fund Advisors, WALL STREET ASSOCIATES, ALTRINSIC GLOBAL ADVISORS LLC, BRIDGEWAY CAPITAL MANAGEMENT INC, STATE STREET CORP, NORTHERN TRUST CORP, SANDERS MORRIS HARRIS INC., and GEODE CAPITAL MANAGEMENT, LLC.
This page lists
43
institutional shareholders reporting positions in this security
for the Q2 2016 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.